New treatments in noninfectious uveitis

Elisabetta Miserocchi, Giulio Modorati, C. Stephen Foster

Research output: Book/ReportBook

2 Citations (Scopus)

Abstract

A complete overview of treatment strategies and new therapeutic options Uveitis is a potentially blinding inflammatory disease that presents one of the most serious and complicated therapeutic challenges in the field of ophthalmology. During the last decade, the therapeutic armamentarium of the uveitis specialist has enormously expanded. Novel biologic agents and intraocular therapy are becoming a valuable alternative treatment to control ocular inflammatory diseases and inflammatory macular edema -- the most important cause of visual loss in patients with uveitis. This publication is designed to bring together the principles of therapy of patients with noninfectious uveitis and the most recent therapeutic options available. General ophthalmologists, uveitis specialists as well as residents will find it a useful update on the latest innovative treatment options for patients with noninfectious uveitis.

Original languageEnglish
PublisherS. Karger AG
Number of pages166
ISBN (Print)9783805599870, 9783805599863
DOIs
Publication statusPublished - Apr 20 2012

Fingerprint

Uveitis
Therapeutics
Macular Edema
Eye Diseases
Biological Factors
Ophthalmology

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Cite this

New treatments in noninfectious uveitis. / Miserocchi, Elisabetta; Modorati, Giulio; Stephen Foster, C.

S. Karger AG, 2012. 166 p.

Research output: Book/ReportBook

Miserocchi, Elisabetta ; Modorati, Giulio ; Stephen Foster, C. / New treatments in noninfectious uveitis. S. Karger AG, 2012. 166 p.
@book{a92349d58f8a42d6be87ab8eaece9206,
title = "New treatments in noninfectious uveitis",
abstract = "A complete overview of treatment strategies and new therapeutic options Uveitis is a potentially blinding inflammatory disease that presents one of the most serious and complicated therapeutic challenges in the field of ophthalmology. During the last decade, the therapeutic armamentarium of the uveitis specialist has enormously expanded. Novel biologic agents and intraocular therapy are becoming a valuable alternative treatment to control ocular inflammatory diseases and inflammatory macular edema -- the most important cause of visual loss in patients with uveitis. This publication is designed to bring together the principles of therapy of patients with noninfectious uveitis and the most recent therapeutic options available. General ophthalmologists, uveitis specialists as well as residents will find it a useful update on the latest innovative treatment options for patients with noninfectious uveitis.",
author = "Elisabetta Miserocchi and Giulio Modorati and {Stephen Foster}, C.",
year = "2012",
month = "4",
day = "20",
doi = "10.1159/isbn.978-3-8055-9987-0",
language = "English",
isbn = "9783805599870",
publisher = "S. Karger AG",

}

TY - BOOK

T1 - New treatments in noninfectious uveitis

AU - Miserocchi, Elisabetta

AU - Modorati, Giulio

AU - Stephen Foster, C.

PY - 2012/4/20

Y1 - 2012/4/20

N2 - A complete overview of treatment strategies and new therapeutic options Uveitis is a potentially blinding inflammatory disease that presents one of the most serious and complicated therapeutic challenges in the field of ophthalmology. During the last decade, the therapeutic armamentarium of the uveitis specialist has enormously expanded. Novel biologic agents and intraocular therapy are becoming a valuable alternative treatment to control ocular inflammatory diseases and inflammatory macular edema -- the most important cause of visual loss in patients with uveitis. This publication is designed to bring together the principles of therapy of patients with noninfectious uveitis and the most recent therapeutic options available. General ophthalmologists, uveitis specialists as well as residents will find it a useful update on the latest innovative treatment options for patients with noninfectious uveitis.

AB - A complete overview of treatment strategies and new therapeutic options Uveitis is a potentially blinding inflammatory disease that presents one of the most serious and complicated therapeutic challenges in the field of ophthalmology. During the last decade, the therapeutic armamentarium of the uveitis specialist has enormously expanded. Novel biologic agents and intraocular therapy are becoming a valuable alternative treatment to control ocular inflammatory diseases and inflammatory macular edema -- the most important cause of visual loss in patients with uveitis. This publication is designed to bring together the principles of therapy of patients with noninfectious uveitis and the most recent therapeutic options available. General ophthalmologists, uveitis specialists as well as residents will find it a useful update on the latest innovative treatment options for patients with noninfectious uveitis.

UR - http://www.scopus.com/inward/record.url?scp=84925878473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925878473&partnerID=8YFLogxK

U2 - 10.1159/isbn.978-3-8055-9987-0

DO - 10.1159/isbn.978-3-8055-9987-0

M3 - Book

AN - SCOPUS:84925878473

SN - 9783805599870

SN - 9783805599863

BT - New treatments in noninfectious uveitis

PB - S. Karger AG

ER -